Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1996-5-28
pubmed:abstractText
Susceptibility to herpes virus infections has been described in experimental animals depleted of NK cells and in patients with defective NK cell function. We have identified a child with recurrent infections, especially with herpes simplex virus, who had a decreased number of CD56(+)CD3(-) NK cells in circulation. Her NK cells expressed an altered form of the Fc receptor for IgG type IIIA (Fc gamma RIIIA or CD16-II) which was not reactive with the anti-CD16-II MoAb B73.1. Sequence analysis revealed the patient to be homozygous for a T to A substitution at position 230 of CD16-II cDNA, predicting a Leu(66) to His(66) change in the first immunoglobulin domain of CD16-II at the B73.1 recognition site. Spontaneous NK cell activity of the patient's peripheral blood mononuclear cells (PBMC) was markedly decreased, while antibody-dependent cellular cytotoxicity (ADCC) was unaffected. These results suggest that this child suffers from a defect affecting the development and function of NK cells, resulting in NK cytopenia and clinically significant immunodeficiency. The role of the CD16-II mutant in the pathogenesis of the patient's NK cell deficiency is discussed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-1692080, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-1703781, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-1710251, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-1910686, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2139697, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2471777, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2521732, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2526846, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2531918, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2531919, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2553809, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2642532, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2967435, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2967436, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-2981954, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-6233371, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-6309965, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-6945311, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-7512596, http://linkedlifedata.com/resource/pubmed/commentcorrection/8608639-7621077
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
408-13
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II).
pubmed:affiliation
Division of Immunology, The Children's Hospital, Boston, MA, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Case Reports, Research Support, Non-U.S. Gov't